CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer
Authors
Anne Sofie Brems-Eskildsen
Hella Danø
+8 more
Trine Dongsgaard
Erik Hugger Jakobsen
Charlotte Buch Jensen
Sven Tyge Langkjer
Søren Linnet
Adam Luczak
Jeppe Neimann
Peter Michael Vestlev
Publication date
1 February 2021
Publisher
'Informa UK Limited'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
VBN
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:pure.atira.dk:publications...
Last time updated on 24/12/2020